Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.

The post Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.